abstract |
The invention belongs to the field of medicine and chemical industry, and relates to a nucleotide phosphonate compound, its pharmaceutical composition, preparation method and application. Specifically, the present invention relates to a class of acyclic nucleotide phosphonate compounds represented by general formula I and their pharmaceutically acceptable inorganic or organic salts and preparation methods, as well as compositions containing compounds of general formula I . The compounds of the present invention can be used as active substances for the treatment and/or prevention of viral infectious diseases. |